physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health

The catheters approved by the FDA include the Plato 17, a DMSO-compatible microcatheter, and the Socrates 38, an aspiration catheter specifically designed for treating ischemic strokes.

Treatment marks the first dissolving stent approved in the United States for treating chronic limb-threatening ischemia in arteries below the knee.

Technology designed to effectively address blood clots by combining capabilities of larger devices with smaller catheters.

Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.

Decree comes amid the FDA’s 2021 inspection of Philips’ Murrysville facility and the subsequent voluntary recall of its sleep and respiratory care devices.

The concussion test, which shows results after 15 minutes, can help evaluate patients up to 24 hours after injury, company says.